Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bowker

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Medicine & Science in Sports|June 14, 2016
Quantifying levels of function between different subgroups of chronic ankle instabilityM Terada, S Bowker, C E Hiller, et al.
Journal of Medicinal Chemistry|June 14, 2012
Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017)James S Scott, Suzanne S Bowker, Joanne Deschoolmeester, et al.
Journal of Medicinal Chemistry|October 7, 2014
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonistsJames S Scott, Suzanne S Bowker, Katy J Brocklehurst, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Discovery, synthesis and biological evaluation of novel glucokinase activatorsDarren McKerrecher, Joanne V Allen, Suzanne S Bowker, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetesWilliam McCoull, Matthew S Addie, Alan M Birch, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Medicine & Science in Sports|June 14, 2016
Quantifying levels of function between different subgroups of chronic ankle instabilityM Terada, S Bowker, C E Hiller, et al.
Journal of Medicinal Chemistry|June 14, 2012
Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017)James S Scott, Suzanne S Bowker, Joanne Deschoolmeester, et al.
Journal of Medicinal Chemistry|October 7, 2014
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonistsJames S Scott, Suzanne S Bowker, Katy J Brocklehurst, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Discovery, synthesis and biological evaluation of novel glucokinase activatorsDarren McKerrecher, Joanne V Allen, Suzanne S Bowker, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetesWilliam McCoull, Matthew S Addie, Alan M Birch, et al.
Pageof 1